These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9375805)

  • 21. Involvement of calpain in hypoxia-induced damage in rat retina in vitro.
    Tamada Y; Fukiage C; Daibo S; Yoshida Y; Azuma M; Shearer TR
    Comp Biochem Physiol B Biochem Mol Biol; 2002 Feb; 131(2):221-5. PubMed ID: 11818243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of calpain to cellular damage in human retinal pigment epithelial cells cultured with zinc chelator.
    Tamada Y; Walkup RD; Shearer TR; Azuma M
    Curr Eye Res; 2007 Jun; 32(6):565-73. PubMed ID: 17612972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of calpain in diamide-induced cataract in cultured lenses.
    Azuma M; Shearer TR
    FEBS Lett; 1992 Aug; 307(3):313-7. PubMed ID: 1644187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of calpain Lp82-induced proteolysis to experimental cataractogenesis in mice.
    Nakamura Y; Fukiage C; Shih M; Ma H; David LL; Azuma M; Shearer TR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1460-6. PubMed ID: 10798663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of calpain in hydrogen peroxide induced cataract.
    Kadoya K; Azuma M; David LL; Shearer TR
    Curr Eye Res; 1993 Apr; 12(4):341-6. PubMed ID: 8319493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased sensitivity of lens-specific calpain Lp82 to calpastatin inhibitor.
    Nakamura Y; Fukiage C; Ma H; Shih M; Azuma M; Shearer TR
    Exp Eye Res; 1999 Aug; 69(2):155-62. PubMed ID: 10433852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of orally available calpain inhibitors 2: peptidyl hemiacetal derivatives.
    Shirasaki Y; Nakamura M; Yamaguchi M; Miyashita H; Sakai O; Inoue J
    J Med Chem; 2006 Jun; 49(13):3926-32. PubMed ID: 16789748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
    Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cataract and the acceleration of calpain-induced beta-crystallin insolubilization occurring during normal maturation of rat lens.
    David LL; Azuma M; Shearer TR
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):785-93. PubMed ID: 8125740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular modeling: a search for a calpain inhibitor as a new treatment for cataractogenesis.
    Stuart BG; Coxon JM; Morton JD; Abell AD; McDonald DQ; Aitken SG; Jones MA; Bickerstaffe R
    J Med Chem; 2011 Nov; 54(21):7503-22. PubMed ID: 21955158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a novel calpain inhibitor as a treatment for cataract.
    Lee HY; Morton JD; Robertson LJ; McDermott JD; Bickerstaffe R; Abell AD; Jones MA; Mehrtens JM; Coxon JM
    Clin Exp Ophthalmol; 2008 Dec; 36(9):852-60. PubMed ID: 19278481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory effect of chrysin on expression of lenticular calcium transporters, calpains, and apoptotic-cascade components in selenite-induced cataract.
    Sundararajan M; Thomas PA; Teresa PA; Anbukkarasi M; Geraldine P
    Mol Vis; 2016; 22():401-23. PubMed ID: 27168717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of orally available calpain inhibitors. Part 3: Dipeptidyl alpha-ketoamide derivatives containing pyridine moiety.
    Shirasaki Y; Miyashita H; Yamaguchi M
    Bioorg Med Chem; 2006 Aug; 14(16):5691-8. PubMed ID: 16651001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoguanidine-treatment results in the inhibition of lens opacification and calpain-mediated proteolysis in Shumiya cataract rats (SCR).
    Inomata M; Hayashi M; Shumiya S; Kawashima S; Ito Y
    J Biochem; 2000 Nov; 128(5):771-6. PubMed ID: 11056389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphoinositide 3-kinase accelerates calpain-dependent proteolysis of fodrin during hypoxic cell death.
    Aki T; Yoshida K; Fujimiya T
    J Biochem; 2002 Dec; 132(6):921-6. PubMed ID: 12473194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for involvement of calpain in c-Myc proteolysis in vivo.
    Small GW; Chou TY; Dang CV; Orlowski RZ
    Arch Biochem Biophys; 2002 Apr; 400(2):151-61. PubMed ID: 12054425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteolysis of neuronal cytoskeletal proteins by calpain contributes to rat retinal cell death induced by hypoxia.
    Tamada Y; Nakajima E; Nakajima T; Shearer TR; Azuma M
    Brain Res; 2005 Jul; 1050(1-2):148-55. PubMed ID: 15979593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the proteolysis of rat erythrocyte membrane proteins by a synthetic inhibitor of calpain.
    Mehdi S; Angelastro MR; Wiseman JS; Bey P
    Biochem Biophys Res Commun; 1988 Dec; 157(3):1117-23. PubMed ID: 2849930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for the involvement of calpain in cataractogenesis in Shumiya cataract rat (SCR).
    Inomata M; Nomura K; Takehana M; Saido TC; Kawashima S; Shumiya S
    Biochim Biophys Acta; 1997 Nov; 1362(1):11-23. PubMed ID: 9434095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation into the P3 binding domain of m-calpain using photoswitchable diazo- and triazene-dipeptide aldehydes: new anticataract agents.
    Abell AD; Jones MA; Neffe AT; Aitken SG; Cain TP; Payne RJ; McNabb SB; Coxon JM; Stuart BG; Pearson D; Lee HY; Morton JD
    J Med Chem; 2007 Jun; 50(12):2916-20. PubMed ID: 17497840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.